• No results found

Cover Page The handle

N/A
N/A
Protected

Academic year: 2021

Share "Cover Page The handle"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The handle http://hdl.handle.net/1887/66268 holds various files of this Leiden University

dissertation.

Author: Heijkants, R.C.

Title: Novel functions of MDMX and innovative therapeutic strategies for melanoma

Issue Date: 2018-10-18

(2)

Novel functions of MDMX and innovative therapeutic

strategies for melanoma

Renier C. Heijkants

(3)

Cover by: Linda van Zijp, StudioLIN.

Lay-out and print by: ProefschriftMaken // www.proefschriftmaken.nl ISBN: -

Copyright 2018 by Renier C. Heijkants, Oss, The Netherlands. All rights reserved.

Copyright of individual chapters lies with the authors, except for chapters 3 and 5.

No part of this thesis may be reproduced, digitalized or transmitted in any form, by any means, electronic or mechanical, including photocopying, recording or by any information storage or retrieval system, without prior permission from the author.

(4)

Novel functions of MDMX and innovative therapeutic strategies for melanoma Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof.mr. C.J.J.M. Stolker,

volgens besluit van het College voor Promoties te verdedigen op donderdag 18 oktober 2018

klokke 13:45 uur door Renier C. Heijkants geboren te Amersfoort

in 1989

(5)

Promotor

Prof. dr. P. ten Dijke Co-promotor Dr. A.G. Jochemsen Promotiecommissie Prof. dr. M.J. Jager

Prof. dr. B.M.T. Burgering (Universitair Medisch Centrum Utrecht) Prof. dr. B.E. Snaar-Jagalska (Universiteit Leiden)

Dr. R. van Doorn

(6)

‘Imagine’

John Lennon

9 oktober 1940 – 8 december 1980

(7)
(8)

Table of contents

Chapter 1 General introduction 9

Chapter 2 MDMX regulates transcriptional activity of p53 and FOXO 37 Chapter 3 Targeting MDMX and PKCδ to improve current uveal melanoma

therapeutic strategies

77

Chapter 4 Combined EZH2 and HDAC inhibition as novel therapeutic intervention for metastasized uveal melanoma

103

Chapter 5 Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma

123

Chapter 6 General discussion 153

Appendix Dutch summary 172

Curriculum Vitae 180

List of publications 181

Acknowledgements 183

List of abbreviations 185

(9)

Referenties

GERELATEERDE DOCUMENTEN

In conclusion, our data show that the synergistic effects of p53 activation by MDM2 inhibition and broad spectrum PKC inhibition on survival of UM cells can also largely be

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded

Het onderzoek van dit proefschrift is gefinancierd door de Mozaiekbeurs (017.003.059) van De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Landelijke Stichting

Since we already know that therapeutic long peptide vaccination alone is not effective in a mouse melanoma model, we describe in Chapter 9 the effect of the additional use of

CD11b+ macrophages have been attributed a role in T cell regulation, and McKenna and Kapp 59 showed that they are also involved in immune regulation against intraocular tumors

Conclusions: Monosomy 3 in uveal melanoma is associated with the presence of an inflammatory phenotype, consisting of a high HLA Class I and II expression as well

As M2-type macrophages are pro-angiogenic, the high density of especially these cells in uveal melanoma may contribute to the increased vascular density that was previously noticed

We determined the presence of 15 cytokines related to inflammation in 37 eyes with uveal melanoma, and compared the concentration of different cytokines to standard